Gland Pharma Ltd
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
01 / The disclosure
What the company shared
Investment by Gland Pharma Limited in Gland Pharma USA Inc. and Investment by Gland Pharma USA Inc. into Novelstar Pharma Inc.
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
USD 21 millionPage 1
Investment of USD 21 million by the Company in Gland Pharma USA Inc.
View source pageThe evidence
Read the source excerpts
01Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors (the “ Board”) of Gland Pharma Limited (the “ Company”), at its meeting held today, i.e., Thursday, October 01, 2026, has, inter-alia, considered and approved:
Page 1
02Investment of USD 21 million by the Company in Gland Pharma USA Inc.
Page 1
03Mr. Wenjie Zhang (DIN: 10727581), Non -Executive & Non -Independent Director , has tendered resignation to his office as a Director due to his pre-occupations.
Page 1
04HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, along with a copy of his resignation letter with detailed reasons thereof are set out in Annexure C and Annexure D respectively.
Page 1
05Appointment of Mr. Xingli Wang (DIN: 11899926), as an Additional Director (Non -Executive & Non-Independent Director) of the Company with effect from October 01, 2026.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 41faa968-38a8-493c-8f75-233f71020102
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 1 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- 89817c0354868d784b6d3f75955929d70c87a9270c5d5d6efc3d6a425cb80a37